# Whole-package self-review

## Review method

The author performed a separate pass after the package tests because no independent subagent/reviewer tool was available. This is weaker than a fresh scientific/code review and is appropriate only for a draft PR.

## Review focus

- compliance with the user-required document/schema/template/matrix/prompt inventory;
- preservation of acquisition/analysis boundaries;
- patient/specimen/assay and raw/canonical endpoint separation;
- row-order-invariant longitudinal design;
- fail-closed assay, overlap, exposure and final-test rules;
- public/private boundary;
- exact historical-code incompatibilities without unsupported claims;
- bounded tickets with inputs/outputs, tests, tracers and review gates.

## Findings

No critical or important structural defect remained after the final pass. The ticket table was strengthened to include explicit input/output schemas, tests and review requirements. Schema `$id` values were changed from a placeholder domain to stable repository raw URLs. The appraisal was annotated to distinguish the approved specification phase from unimplemented source/data work.

## Remaining limitations

- no populated registry or real source object;
- no independent scientific reviewer;
- no repository-wide or AIU run;
- no proof that source-specific unknowns are resolvable;
- JSON schemas specify contracts but do not implement relational cross-table constraints; those belong to DAV-T04–T14.

Disposition: suitable for draft review, not merge or analysis release.
